Screening and characterization of potential small molecule antagonists of myostatin.
Sarcopenia is the progressive loss of skeletal muscle mass and strength associated with aging. Current treatment of sarcopenia with hormone replacement therapy has been shown to have significant health risks, while exercise therapy is useful but cannot be prescribed in all cases of sarcopenia, often...
Saved in:
Main Author: | Lee, Rachel Hui Min. |
---|---|
Other Authors: | Susana Geifman Shochat |
Format: | Final Year Project |
Language: | English |
Published: |
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/49350 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Treatment of sarcopenia by antagonists of myostatin
by: Anissa Anindya Widjaja
Published: (2013) -
Regulation of muscle metabolism by myostatin
by: Zhang, Chen
Published: (2012) -
Small-molecule vasopressin-2 receptor antagonist identified by a G-protein coupled receptor "pathway" screen
by: Buranee Yangthara, et al.
Published: (2018) -
[Withdrawn] Regulation of insulin resistance by myostatin
by: Sabeera Bonala
Published: (2013) -
The regulation of cancer cachexia and colorectal carcinogenesis by myostatin
by: Wijesoma, Isuru Wijerupage
Published: (2017)